The expression of p16 in nephrogenic adenoma is unique and new to the literature.The differential diagnosis includes clear cell carcinoma, urothelial carcinoma with p16 expression and prostatic adenocarcinoma. Here, CDKN2A is linked to prostate adenocarcinoma.